News Sanofi faces EU antitrust probe into vaccine business Sanofi has confirmed it is being investigated by the European Commission for potentially anticompetitive activity in its vaccines business.
R&D How Europe can harness the full potential of biosimilars Biosimilars - clinically equivalent alternatives to original biologic drugs - play a vital role in addressing unmet health needs.
R&D No longer the little fish: How Europe is holding its own thr... It goes without saying that we are living in uncertain times, yet, this holds particularly true for the pharmaceutical industry.
Market Access Neurotech patents in Europe: Methods, medical devices, and t... The field of neurotechnology is rapidly evolving, bringing together advances in neuroscience, engineering, materials science, and computing.
Market Access Early strategic evidence planning is a key success factor in... As the European Union (EU) ushers in a new era of health technology regulation, pharmaceutical companies face both unprecedented challenges and opportunities.
News J&J's oral IL-23 drug backed for psoriasis in EU J&J's oral psoriasis drug Icotyde heads up the list of new therapies recommended for EU approval at the CHMP's July meeting.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.